Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 15(10): e0240309, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33075098

RESUMO

INTRODUCTION: Etiology studies of severe acute respiratory infections (SARI) in adults are limited. We studied potential etiologies of SARI among adults in six countries using multi-pathogen diagnostics. METHODS: We enrolled both adults with SARI (acute respiratory illness onset with fever and cough requiring hospitalization) and asymptomatic adults (adults hospitalized with non-infectious illnesses, non-household members accompanying SARI patients, adults enrolled from outpatient departments, and community members) in each country. Demographics, clinical data, and nasopharyngeal and oropharyngeal specimens were collected from both SARI patients and asymptomatic adults. Specimens were tested for presence of 29 pathogens utilizing the Taqman® Array Card platform. We applied a non-parametric Bayesian regression extension of a partially latent class model approach to estimate proportions of SARI caused by specific pathogens. RESULTS: We enrolled 2,388 SARI patients and 1,135 asymptomatic adults from October 2013 through October 2015. We detected ≥1 pathogen in 76% of SARI patients and 67% of asymptomatic adults. Haemophilus influenzae and Streptococcus pneumoniae were most commonly detected (≥23% of SARI patients and asymptomatic adults). Through modeling, etiology was attributed to a pathogen in most SARI patients (range among countries: 57.3-93.2%); pathogens commonly attributed to SARI etiology included influenza A (14.4-54.4%), influenza B (1.9-19.1%), rhino/enterovirus (1.8-42.6%), and RSV (3.6-14.6%). CONCLUSIONS: Use of multi-pathogen diagnostics and modeling enabled attribution of etiology in most adult SARI patients, despite frequent detection of multiple pathogens in the upper respiratory tract. Seasonal flu vaccination and development of RSV vaccine would likely reduce the burden of SARI in these populations.


Assuntos
Bactérias/classificação , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/microbiologia , Vírus/classificação , Adulto , Idoso , Doenças Assintomáticas/epidemiologia , Bactérias/genética , Bactérias/isolamento & purificação , Bangladesh , Teorema de Bayes , Feminino , Guatemala , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Teóricos , Epidemiologia Molecular , Nasofaringe/microbiologia , Orofaringe/microbiologia , Reação em Cadeia da Polimerase , Vírus/genética , Vírus/isolamento & purificação , Adulto Jovem
2.
J Infect Dis ; 208 Suppl 3: S246-54, 2013 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-24265484

RESUMO

BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children globally, with the highest burden in low- and middle-income countries where the association between RSV activity and climate remains unclear. METHODS: Monthly laboratory-confirmed RSV cases and associations with climate data were assessed for respiratory surveillance sites in tropical and subtropical areas (Bangladesh, China, Egypt, Guatemala, Kenya, South Africa, and Thailand) during 2004-2012. Average monthly minimum and maximum temperatures, relative humidity, and precipitation were calculated using daily local weather data from the US National Climatic Data Center. RESULTS: RSV circulated with 1-2 epidemic periods each year in site areas. RSV seasonal timing and duration were generally consistent within country from year to year. Associations between RSV and weather varied across years and geographic locations. RSV usually peaked in climates with high annual precipitation (Bangladesh, Guatemala, and Thailand) during wet months, whereas RSV peaked during cooler months in moderately hot (China) and arid (Egypt) regions. In South Africa, RSV peaked in autumn, whereas no associations with seasonal weather trends were observed in Kenya. CONCLUSIONS: Further understanding of RSV seasonality in developing countries and various climate regions will be important to better understand the epidemiology of RSV and for timing the use of future RSV vaccines and immunoprophylaxis in low- and middle-income countries.


Assuntos
Países em Desenvolvimento/estatística & dados numéricos , Infecções por Vírus Respiratório Sincicial/epidemiologia , Vírus Sincicial Respiratório Humano/isolamento & purificação , Infecções Respiratórias/epidemiologia , Adulto , Bangladesh/epidemiologia , Centers for Disease Control and Prevention, U.S. , Criança , Pré-Escolar , China/epidemiologia , Clima , Surtos de Doenças , Egito/epidemiologia , Feminino , Guatemala/epidemiologia , Humanos , Lactente , Agências Internacionais , Quênia/epidemiologia , Masculino , Vigilância da População/métodos , Infecções por Vírus Respiratório Sincicial/virologia , Vírus Sincicial Respiratório Humano/genética , Infecções Respiratórias/virologia , Estações do Ano , África do Sul/epidemiologia , Tailândia/epidemiologia , Estados Unidos , Tempo (Meteorologia)
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA